ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

VTGN Vistagen Therapeutics Inc

2.60
0.35 (15.56%)
21 Dec 2024 - Closed
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Quarter End Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue -893k180k176k178k277k412k197k84k
Operating Income -17.49M-9.77M-12.24M-7M-6.78M-7.88M-11.36M-12.13M
Pre Tax Income -17.48M-9.76M-12.23M-6.9M-6.59M-6.35M-9.52M-10.73M
Net Income -17.48M-9.76M-12.23M-6.9M-6.59M-6.35M-9.52M-10.73M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -17.49M-9.77M-12.24M-7M-6.78M-7.88M-11.05M-12.13M
EBITDA -17.46M-9.74M-12.21M-6.97M-6.75M-7.85M-11.33M-12.1M
Year End 31 March 2024 20172018201920202021202220232024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 1.25M0001.09M1.11M-227k1.06M
Operating Income -10.25M-14.2M-24.56M-20.8M-17.93M-47.78M-59.27M-33.02M
Pre Tax Income -10.25M-14.34M-24.59M-20.77M-17.93M-47.76M-59.24M-29.36M
Net Income -11.62M-15.58M-25.73M-22.04M-42.32M-48.71M-59.25M-29.36M
Preferred Dividends -1.37M-1.23M-1.14M-1.26M-24.39M-946k00
Basic Earnings Per Share (EPS) -0.873-0.576-0.552-0.413-0.229-0.231-0.281-0.948
EBIT -10.25M-14.34M-24.58M-20.8M-17.93M-47.78M-59.27M-32.71M
EBITDA -10.19M-14.12M-24.47M-20.7M-17.82M-47.63M-59.14M-32.89M

Your Recent History

Delayed Upgrade Clock